What Is Access Execution? Defining the Layer Between Payer Data and Field Behavior 

A therapy can be covered on paper and still out of reach in practice. 

The policy exists, and the formulary lists it. The payer’s own documentation may support patient coverage. And still the start date slips, a prior authorization form may be out of date, a field team member may not be aware of coverage rules that recently changed, a coordinator may not know that the step-therapy requirement was dropped. The coverage is real, but whether it becomes access is another matter entirely. 

The distance between coverage that exists on paper and access a patient experiences is what we at AccessSync call the Access Realization Gap. The work of closing it has a name the market access field has been circling for years without quite defining access execution. 

Access execution is the layer of market access that turns documented payer coverage into realized patient access. It keeps field-facing resources aligned with current policy and puts the right coverage information in front of the right team, at the right account, at the moment a decision gets made. 

Why the category has been hard to see 

Ask a colleague, or an AI assistant, to compare market access vendors, and you’ll usually get a list that includes data providers, CRM platforms, and execution partners lined up as interchangeable options. Each, however, occupies a different layer of the same stack, and because no one had drawn the boundaries between those layers, access execution kept getting absorbed into whichever category a buyer already recognized. 

Naming the layers is what makes the picture more legible. 

The three layers of the market access stack 

Three distinct functions sit between a payer’s coverage decision and a patient’s therapy. Each is essential and distinct. A market access team needs all three. 

Layer	The question it answers	Supplier
Access data	What coverage exists on paper?	MMIT, Policy Reporter, Clarivate, IQVIA, etc.
Field / CRM	What are teams doing in the field?	Veeva, Salesforce
Access execution	Is coverage on paper becoming access in practice?	AccessSync

The Access data layer indicates what the landscape allows, formulary status, coverage policy, prior authorization and step-therapy criteria. The field layer records what teams do: calls made, accounts touched, engagement logged. Both are mature, and both have recognized leaders. 

What has lacked a name is the layer between them: the one that takes what the data says is covered and makes sure the field acts on it, accurately and in time. A team doesn’t choose between access data and a CRM; it runs on both.

Access execution is the third necessity which is the connective layer that decides whether everything documented in the first two becomes real for a patient. AccessSync is built to operationalize this layer and to transfer what access data documents into the actions a field team takes, so coverage on paper becomes access in practice. 

From policy to field action 

A single payer change highlights the function of each layer. Suppose a plan updates a step-therapy requirement on a covered therapy. In the access data layer, that change exists the moment it is published as a revised line in a policy document. For it to become access, it has to first be verified against the payer’s language, then translated into what it means for a specific account and finally delivered to the field rep managing that account prior to the next patient conversation. 

Access execution is the work that carries a policy change from a criterion in a formulary to a field team that knows what changed, and what to do about it. Payer data can inform you of the criterion status. A CRM can record the call once it happens. The execution layer moves the information from the first to the second in time to improve patient access. 

Why access execution matters now 

The gap between paper and practice widens under three pressures that define today’s market: 

• Policy velocity. Prior authorization, step-therapy, and formulary criteria change continually.  

• Launch density. Emerging and mid-size biopharma increasingly run several launches at once, each with its own payer landscape, and usually under intense time pressure. 

• Lean structure. Many biopharma companies have no standing access-operations function. The work still has to happen; there’s simply no team named to own it. 

The cost of that gap is measurable. Ninety-five percent of physicians report that prior authorization delays patients’ access to necessary care, and more than one in four say the prior-authorization information in their electronic health records may often be inaccurate. ¹ Each pressure widens the Access Realization Gap.

Access execution is the discipline that closes the gap as conditions shift, which is why its value shows up in the terms leaders already track: faster time to therapy, greater field readiness, coordinated execution across accounts, and less friction between the coverage that exists and the access a patient receives. 

What good access execution requires 

Because this layer creates value when field utilization grows, three qualities define genuine access execution: 

• Current — it reflects policy as it changes, so a rep is working from accurate and timely information. 

• Usable where the work happens — it reaches teams in the flow of their day; at the point a coverage decision is made. 

• Trusted — field teams act on it because they’ve learned it’s credible . Confidence is what converts information into action. 

These are the working conditions that enable documented coverage to support the patient journey. 

The key access question 

For a market access leader, the most useful question is a plain one: is the coverage your data already documents actually reaching patients as access? That is the work of the execution layer, and naming it is the first step toward resourcing it. 

We’ll go deeper into what that work involves: how quickly prior authorization policy actually changes, what access execution looks like for a team without an access-operations function, and where it earns its place in a lean, fast-moving launch. 

Coverage on paper is a promise. Access execution is how the promise gets kept. 

See AccessSync in action  

Discover how AccessSync customers are turning coverage data into confident HCP conversations — in a 30-minute demo tailored to your brand. Schedule a meeting. 

Notes 

1. American Medical Association, 2025 AMA Prior Authorization Physician Survey (Chicago: American Medical Association, 2026), https://www.ama-assn.org/system/files/prior-authorization-survey.pdf.